273 related articles for article (PubMed ID: 21155387)
1. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery.
Abdelkader H; Ismail S; Kamal A; Alany RG
J Pharm Sci; 2011 May; 100(5):1833-46. PubMed ID: 21246556
[TBL] [Abstract][Full Text] [Related]
3. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.
Abdelkader H; Wu Z; Al-Kassas R; Alany RG
Int J Pharm; 2012 Aug; 433(1-2):142-8. PubMed ID: 22595640
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
Pardakhty A; Varshosaz J; Rouholamini A
Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.
Yang DB; Zhu JB; Huang ZJ; Ren HX; Zheng ZJ
Colloids Surf B Biointerfaces; 2008 Jun; 63(2):192-9. PubMed ID: 18295461
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
8. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
Yeom S; Shin BS; Han S
Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
[TBL] [Abstract][Full Text] [Related]
9. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of niosomes containing rifampicin for lung targeting.
Jain CP; Vyas SP
J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid.
Manosroi A; Chutoprapat R; Abe M; Manosroi J
Int J Pharm; 2008 Mar; 352(1-2):248-55. PubMed ID: 18036754
[TBL] [Abstract][Full Text] [Related]
12. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
[TBL] [Abstract][Full Text] [Related]
13. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of niosomes containing ribavirin for liver targeting.
Hashim F; El-Ridy M; Nasr M; Abdallah Y
Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
[TBL] [Abstract][Full Text] [Related]
17. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
[TBL] [Abstract][Full Text] [Related]
18. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
[TBL] [Abstract][Full Text] [Related]
19. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
Mokhtar M; Sammour OA; Hammad MA; Megrab NA
Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
[TBL] [Abstract][Full Text] [Related]
20. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
